CS
Candriam SCA Portfolio holdings
AUM
$17.3B
1-Year Return
21.68%
This Quarter Return
+8.93%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$14.4B
AUM Growth
-$406M
(-2.7%)
Cap. Flow
-$236M
Cap. Flow
% of AUM
-1.64%
Top 10 Holdings %
Top 10 Hldgs %
24.27%
Holding
963
New
98
Increased
340
Reduced
353
Closed
82
Top Buys
| 1 |
ZTO Express
ZTO
|
$42.9M |
| 2 |
STKL
SunOpta
STKL
|
$39.6M |
| 3 |
Kanzhun
BZ
|
$36.9M |
| 4 |
JPMorgan Chase
JPM
|
$35M |
| 5 |
Lantheus
LNTH
|
$30.3M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$85.2M |
| 2 |
Microsoft
MSFT
|
$60.8M |
| 3 |
Veru
VERU
|
$53.9M |
| 4 |
Procter & Gamble
PG
|
$48.4M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$42.9M |
Sector Composition
| 1 | Healthcare | 30.95% |
| 2 | Technology | 26.5% |
| 3 | Financials | 9.1% |
| 4 | Consumer Discretionary | 8.02% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
751
Owens & Minor
OMI
$434M
| $454K | ﹤0.01% |
33,879
-8,373
| -20% | -$112K |
|
752
RadNet
RDNT
$5.49B
| $451K | ﹤0.01% |
19,563
-25,129
| -56% | -$579K |
|
|
RETA
753
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $450K | ﹤0.01% |
+5,377
| New | +$450K |
|
754
Yelp
YELP
$2.02B
| $448K | ﹤0.01% |
15,843
+2,802
| +21% | +$79.2K |
|
755
New York Times
NYT
$9.6B
| $448K | ﹤0.01% |
12,508
+1,704
| +16% | +$61K |
|
756
Theravance Biopharma
TBPH
$703M
| $444K | ﹤0.01% |
44,489
-38,713
| -47% | -$387K |
|
757
Organon & Co
OGN
$2.7B
| $443K | ﹤0.01% |
+20,486
| New | +$443K |
|
758
Ziff Davis
ZD
$1.56B
| $441K | ﹤0.01% |
6,135
+1,899
| +45% | +$136K |
|
|
SYNH
759
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $438K | ﹤0.01% |
+13,373
| New | +$438K |
|
|
NARI
760
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $438K | ﹤0.01% |
7,713
-5,096
| -40% | -$290K |
|
761
ZipRecruiter
ZIP
$421M
| $438K | ﹤0.01% |
+29,854
| New | +$438K |
|
762
IAC Inc
IAC
$2.98B
| $436K | ﹤0.01% |
11,184
+1,611
| +17% | +$62.8K |
|
763
Select Medical
SEM
$1.62B
| $433K | ﹤0.01% |
33,774
-36,628
| -52% | -$470K |
|
|
MODV
764
DELISTED
ModivCare
MODV
| $431K | ﹤0.01% |
+5,571
| New | +$431K |
|
765
Varex Imaging
VREX
$484M
| $431K | ﹤0.01% |
25,735
-18,689
| -42% | -$313K |
|
766
Paylocity
PCTY
$9.62B
| $430K | ﹤0.01% |
+2,352
| New | +$430K |
|
767
Encompass Health
EHC
$12.6B
| $430K | ﹤0.01% |
8,635
-7,025
| -45% | -$350K |
|
|
PDCO
768
DELISTED
Patterson Companies, Inc.
PDCO
| $430K | ﹤0.01% |
17,445
-13,737
| -44% | -$338K |
|
769
Agios Pharmaceuticals
AGIO
$2.09B
| $426K | ﹤0.01% |
+20,160
| New | +$426K |
|
770
Alcoa
AA
$8.24B
| $421K | ﹤0.01% |
10,743
-1,392
| -11% | -$54.5K |
|
771
Clear Channel Outdoor Holdings
CCO
$656M
| $421K | ﹤0.01% |
380,761
+15,219
| +4% | +$16.8K |
|
772
Bath & Body Works
BBWI
$6.06B
| $420K | ﹤0.01% |
12,480
| – | – |
|
|
PRVB
773
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $420K | ﹤0.01% |
18,922
-78,587
| -81% | -$1.74M |
|
774
Phathom Pharmaceuticals
PHAT
$875M
| $419K | ﹤0.01% |
63,778
-19,579
| -23% | -$129K |
|
775
Enovis
ENOV
$1.84B
| $419K | ﹤0.01% |
8,506
-7,922
| -48% | -$390K |
|